These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36448650)

  • 21. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
    Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
    Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
    van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
    Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care.
    Delesie M; Ballet A; Hillegeer C; Desteghe L; Dendale P; Heidbuchel H
    Clin Drug Investig; 2022 Sep; 42(9):775-786. PubMed ID: 35986867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Caso V; de Groot JR; Sanmartin Fernandez M; Segura T; Blomström-Lundqvist C; Hargroves D; Antoniou S; Williams H; Worsley A; Harris J; Caleyachetty A; Vardar B; Field P; Ruff CT
    Heart; 2023 Jan; 109(3):178-185. PubMed ID: 36316100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey.
    Fuat A; Ako E; Hargroves D; Holden D; Caleyachetty A; Carter M; Harris J; Roberts C; Nzeakor N; Vardar B; Williams H
    J Mark Access Health Policy; 2023; 11(1):2267327. PubMed ID: 37954532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
    Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.
    Zhang ZX; van de Garde EMW; Söhne M; Harmsze AM; van den Broek MPH
    Br J Clin Pharmacol; 2020 Aug; 86(8):1567-1574. PubMed ID: 32090369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand.
    Wattanaruengchai P; Nathisuwan S; Rattanavipanon W; Chulavatnatol S; Kongwatcharapong J; Mitsuntisuk P; Chaiyasothi T; Kritsanapipat D; Phrommintikul A; Chaiyakunapruk N; Likittanasombat K; Lip GYH
    Br J Clin Pharmacol; 2021 Mar; 87(3):1390-1400. PubMed ID: 32857417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation.
    Carbone A; Santelli F; Bottino R; Attena E; Mazzone C; Parisi V; D'Andrea A; Golino P; Nigro G; Russo V
    Eur J Clin Pharmacol; 2022 May; 78(5):879-886. PubMed ID: 35138442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.
    Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M
    Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Direct Oral Anticoagulants in Canadian Primary Care Practice 2010-2015: A Cohort Study From the Canadian Primary Care Sentinel Surveillance Network.
    McAlister FA; Garrison S; Kosowan L; Ezekowitz JA; Singer A
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry.
    Poli D; Antonucci E; Ageno W; Berteotti M; Falanga A; Pengo V; Chiarugi P; Cosmi B; Paparo C; Chistolini A; Insana A; Lione D; Malcangi G; Martini G; Masciocco L; Pedrini S; Bucherini E; Pastori D; Pignatelli P; Toma A; Testa S; Palareti G; Start Af Study Group
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610775
    [No Abstract]   [Full Text] [Related]  

  • 35. Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
    Sugrue A; Sanborn D; Amin M; Farwati M; Sridhar H; Ahmed A; Mehta R; Siontis KC; Mulpuru SK; Deshmukh AJ; Gersh BJ; Asirvatham SJ; Madhavan M
    Am J Cardiol; 2021 Apr; 144():52-59. PubMed ID: 33385355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.
    Baker D; Wilsmore B; Narasimhan S
    Intern Med J; 2016 Jul; 46(7):792-7. PubMed ID: 27040617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.
    Chan YH; Chao TF; Chen SW; Lee HF; Yeh YH; Huang YC; Chang SH; Kuo CT; Lip GYH; Chen SA
    Heart Rhythm; 2020 Dec; 17(12):2102-2110. PubMed ID: 32702416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality.
    Aguilar F; Lo KB; Quintero EE; Torres RJ; Hung WA; Albano JC; Alviz I; Rodriguez C; Garcia MJ; Romero J; Slipczuk L
    Expert Rev Cardiovasc Ther; 2021 Dec; 19(12):1119-1126. PubMed ID: 34879208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide.
    Capiau A; De Backer T; Grymonprez M; Lahousse L; Van Tongelen I; Mehuys E; Boussery K
    Int J Cardiol; 2021 Apr; 328():97-103. PubMed ID: 33279589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
    Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.